News and Announcements
Altech Chemicals Secures Johor HPA Site
- Published November 28, 2016 9:20AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
25th November 2016, ASX Announcement
Highlights
- Lease signing ceremony secures HPA site at Johor
- 20-year lease agreement, with 20-year renewal option
- Johor is the ideal location for HPA production and distribution
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise the attendance of managing director Iggy Tan at the Johor Corporation official lease signing ceremony. The lease is for the land Altech has secured at the Tanjung Langsat Industrial Complex, Johor, Malaysia as the site of its proposed high purity alumina (HPA) plant.
The Company executed a 20-year lease agreement, which includes a 20-year renewal option, with TPM Technopark Sdn Bhd, a wholly-owned subsidiary of Johor Corporation.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
